Table 3.
Vitamin D and Its Metabolites | COVID-19 Group * (n = 103) |
Control Group * (n = 50) |
p-Value |
---|---|---|---|
Cholecalciferol (ng/mL) | 18.50 ± 5.36 | 29.13 ± 4.94 | ≤0.001 (HS) |
Calcifediol (ng/mL) | 14.60 ± 3.30 | 23.10 ± 3.02 | ≤0.001 (HS) |
Calcitriol (pg/mL) | 42.90 ± 8.44 | 65.15 ± 7.11 | ≤0.001 (HS) |
Cacitriol/Calcifediol ratio (VMR1, pg/ng) | 2.97 ± 0.30 | 2.86 ± 0.46 | NS |
Calcifediol/Cholecalciferol ratio (VMR2, ng/ng) | 0.82 ± 0.14 | 0.81 ± 0.17 | NS |
HS, highly significant; NS, Non-significant; VMR, vitamin D metabolite ratio. * Mean ± standard error of the mean.